Covered recipient · General Payments record
SANDHYA RANI MOKKALA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,390.45
- Reported across 79 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $336.73 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $72.28 | 4 |
| Amgen Inc. | $59.04 | 1 |
| PFIZER INC. | $38.91 | 1 |
| Acerta Pharma LLC | $34.59 | 2 |
| Abbott Laboratories | $31.73 | 2 |
| ABBVIE INC. | $25.80 | 1 |
| Novo Nordisk AS | $22.11 | 1 |
| GlaxoSmithKline, LLC. | $22.02 | 1 |
| Exact Sciences Corporation | $15.78 | 1 |
| Otsuka America Pharmaceutical, Inc. | $14.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $15.74 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125069547 | CMS |
| Abbott Laboratories | $15.99 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125069545 | CMS |
| ABBVIE INC. | $25.80 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105053330 | CMS |
| Amgen Inc. | $59.04 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117632231 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.37 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105899790 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.22 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105360095 | CMS |
| Exact Sciences Corporation | $15.78 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114549619 | CMS |
| GlaxoSmithKline, LLC. | $22.02 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115989739 | CMS |
| Lilly USA, LLC | $23.11 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135414805 | CMS |
| Lilly USA, LLC | $17.69 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135414803 | CMS |
| Lilly USA, LLC | $15.13 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135391299 | CMS |
| Lilly USA, LLC | $16.35 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135404540 | CMS |
| Novo Nordisk Inc | $22.11 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097392038 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.47 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118944617 | CMS |
| PFIZER INC. | $38.91 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131432928 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.